Bristol Myers Squibb invests over $400m in sterile drug product facility 22-Feb-2024 By Isabel Cameron Bristol Myers Squibb is investing over $400 million to build a sterile drug product facility at its Dublin campus.
Exothera to support process development of Turkish company’s COVID-19 vaccine 07-Jul-2022 By Jane Byrne Turkey based Vaccizone has chosen Belgian CDMO, Exothera, to fast-track process development of its COVID-19 vaccine for European clinical trials.
Wuxi STA site passes EMA drug product pre-approval inspection 03-Mar-2022 By Jane Byrne WuXi STA says its drug product facility in Wuxi City, China has successfully passed its first pre-approval inspection (PAI) and received the GMP compliance certificate from the European Medicines Agency (EMA).
